The political decision was made on 24 July during the previous Competitiveness Council, also held in Brussels. In the July meeting, all but the Austrian, Lithuanian, Maltese, Polish and Slovak delegations voted in favour, carrying FP7 through by a substantial qualified majority.
The political agreement came thanks to intervention by the Presidency, where rules for stem cell research were clarified, to the satisfaction of most delegations.
FP7 has been drawn up to give priority to four specific areas:
- Cooperation - collaborative research;
- Ideas - including the establishment of the European Research Council (ERC);
- People - human resources;
FP7 is expected to be easier to negotiate for participants, offer more opportunities for research and researchers, and bring science and society closer.
FP7, including Euratom, has a budget of â¬50.4 billion.
For further information, please read Council Conclusions (.pdf file, 240.54 KB).
Copyright Â©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg â http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.